Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.21 USD | -1.76% | +6.49% | -18.07% |
Business Summary
Number of employees: 919
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Next Generation Sequencing Tools
50.5
%
| 99 | 48.8 % | 124 | 50.5 % | +24.56% |
Synthetic Genes
30.0
%
| 62 | 30.2 % | 74 | 30.0 % | +19.56% |
Antibody Discovery
9.5
%
| 24 | 11.9 % | 23 | 9.5 % | -4.13% |
Oligo Pools
5.9
%
| 12 | 6.1 % | 14 | 5.9 % | +16.62% |
DNA Libraries
4.2
%
| 6 | 3.0 % | 10 | 4.2 % | +65.90% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
61.7
%
| 122 | 60.2 % | 151 | 61.7 % | +23.51% |
EMEA
29.1
%
| 62 | 30.5 % | 71 | 29.1 % | +15.00% |
APAC
9.2
%
| 19 | 9.3 % | 22 | 9.2 % | +18.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Banyai
FOU | Founder | 69 | 13-02-03 |
Emily Leproust
CEO | Chief Executive Officer | 50 | 13-03-31 |
Adam Laponis
DFI | Director of Finance/CFO | 47 | Jan. 04 |
Patrick Finn
PSD | President | 53 | 15-02-02 |
Chet Gandhi
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-19 |
Chief Tech/Sci/R&D Officer | - | 14-02-28 | |
Siyuan Chen
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Aaron Sato
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dennis Cho
CMP | Compliance Officer | 53 | 21-09-26 |
Angela Bitting
IRC | Investor Relations Contact | - | 20-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Ragusa
BRD | Director/Board Member | 64 | 16-10-31 |
Jan Johannessen
BRD | Director/Board Member | 67 | 18-09-30 |
Keith Crandell
BRD | Director/Board Member | 63 | 13-09-30 |
Robert Chess
BRD | Director/Board Member | 66 | 14-05-31 |
Nelson Chan
BRD | Director/Board Member | 62 | 19-04-30 |
William Banyai
FOU | Founder | 69 | 13-02-03 |
Director/Board Member | 58 | 21-08-05 | |
Emily Leproust
CEO | Chief Executive Officer | 50 | 13-03-31 |
Xiaoying Mai
BRD | Director/Board Member | 36 | 18-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,818,022 | 56,786,314 ( 98.22 %) | 0 | 98.22 % |
Company contact information
Twist Bioscience Corp.
681 Gateway Boulevard
94080, San Francisco
+800 719 0671
http://www.twistbioscience.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.07% | 1.78B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-22.81% | 29.36B | |
+57.92% | 24.49B | |
-14.15% | 17.31B | |
-19.11% | 11.62B | |
-13.96% | 11.31B | |
-44.23% | 11.26B | |
+5.24% | 8.31B |
- Stock Market
- Equities
- TWST Stock
- Company Twist Bioscience Corporation